Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs

Clinical and Vaccine Immunology

Volumn 19, Issue 4, 2012, Pages 527-535

  Wagner, Bettina ^a   Freer, Heather ^a   Rollins, Alicia ^a   Garcia Tapia, David ^b   Erb, Hollis N ^a   Earnhart, Christopher ^c   Marconi, Richard ^c   Meeus, Patrick ^b  

^a Cornell University ^*  (United States)

^b ZOETIS   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; C6 ANTIGEN; OUTER SURFACE PROTEIN A; OUTER SURFACE PROTEIN C; OUTER SURFACE PROTEIN F; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BIOASSAY; BLOOD ANALYSIS; BORRELIA BURGDORFERI; CONTROLLED STUDY; DISEASE MARKER; DNA SEQUENCE; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; LYME DISEASE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORRELIA BURGDORFERI; CLINICAL LABORATORY TECHNIQUES; DOG DISEASES; DOGS; FEMALE; IMMUNOASSAY; LYME DISEASE; MALE; UNITED STATES; VETERINARY MEDICINE;

EID: 84859327070     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05653-11     Document Type: Article

References (44)

1. Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC. 1999. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67:173-181. (Pubitemid 29021645)
2. Appel MJG, et al. 1993. Experimental Lyme disease in dogs produces arthritis and persistent infection. J. Infect. Dis. 167:651-664. (Pubitemid 23056332)
3. Chang YF, et al. 1995. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect. Immun. 63:3543-3549.
4. Conlon JA, Mather TN, Tanner P, Gallo G, Jacobson RH. 2000. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Vet. Ther. 1:96-107.
5. Duncan AW, Correa MT, Levine JF, Breitschwerdt EB. 2005. The dog as a sentinel for human infection: prevalence of B. burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonot. Dis. 5:101-109. (Pubitemid 41149680)
6. Fikrig E, Barthold SW, Kantor FS, Flavell RA. 1990. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250:553-556. (Pubitemid 120031784)
7. Grimm D, et al. 2004. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. U. S. A. 101:3142-3147. (Pubitemid 38327748)
8. Guerra MA, Walker ED, Kitron U. 2000. Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure. J. Clin. Microbiol. 38:2628-2632. (Pubitemid 30485140)
9. Hovius JWR, van Dam AP, Fikrig E. 2007. Tick-host-pathogen interaction in Lyme borreliosis. Trends Parasitol. 23:434-438.
10. Hutton TA, et al. 2008. Search for Borrelia burgdorferi in kidneys of dogs with suspected "Lyme nephritis." J. Vet. Intern. Med. 22:860-865.
11. Jacobson RH, Chang YF, Shin SJ. 1996. Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs. Semin. Vet. Med. Surg. (Small Anim.) 11:172-182. (Pubitemid 126804754)
12. Levy SA, Magnarelli LA. 1992. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. J. Am. Vet. Med. Assoc. 200:344-347.
13. Levy SA, et al. 2008. Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs. Clin. Vaccine Immunol. 15:115-119. (Pubitemid 351966540)
14. Liang FT, et al. 1999. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J. Immunol. 163:5566-5573.
15. Liang FT, Philipp MT. 1999. Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect. Immun. 67:6702-6706.
16. Liang FT, Jacobson RH, Straubinger RK, Grooters A, Phillipp MT. 2000. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 38:4160-4166. (Pubitemid 32233220)
17. Lindenmayer J, Weber M, Bryant J, Marquez E, Onderdonk A. 1990. Comparison of indirect immunofluorescent-antibody assay, enzymelinked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs. J. Clin. Microbiol. 28:92-96. (Pubitemid 20016784)
18. Magnarelli LA, Flavell RA, Padula SJ, Anderson JF, Fikrig E. 1997. Serologic diagnosis of canine and equine borreliosis: use of recombinant antigens in enzyme-linked immunosorbent assays. J. Clin. Microbiol. 35: 169-173. (Pubitemid 26422648)
19. Magnarelli LA, et al. 2001. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. J. Med. Microbiol. 50:889-895. (Pubitemid 32905217)
20. Mather TN, SR Telford III, Moore SI, Spielman A. 1990. Borrelia burgdorferi and Babesia microti: efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Exp. Parasitol. 70:55-61. (Pubitemid 20061113)
21. McDowell JV, Sung SY, Price G, Marconi RT. 2001. Demonstration of the genetic stability and temporal expression of select members of the Lyme disease spirochete OspF protein family during infection in mice. Infect. Immun. 69:4831-4838. (Pubitemid 32674462)
22. Morgan E, et al. 2004. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110: 252-266. (Pubitemid 38402005)
23. Pal U, et al. 2000. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Investig. 106:561-569. (Pubitemid 30666389)
24. Pal U, Fikrig E. 2003. Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microb. Infect. 5:659-666. (Pubitemid 36645126)
25. Pal U, et al. 2004. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Investig. 113:220-230. (Pubitemid 38544207)
26. Philipp MT, et al. 2001. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878. (Pubitemid 32881091)
27. Prabhakar U, Eirikis E, Miller BE, Davis HM. 2005. Multiplexed cytokine sandwich immunoassays: clinical applications. Methods Mol. Med. 114:223-232.
28. Ramamoorthi N, et al. 2005. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436:573-577. (Pubitemid 41112932)
29. Schaible UE, et al. 1990. Monoclonal antibodies specific for outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (SCID) mice. Proc. Natl. Acad. Sci. U. S. A. 87:3768-3772.
30. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. 1995. Induction of outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. U. S. A. 92:2909-2913.
31. Shin SJ, et al. 1993. Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs. Vet. Microbiol. 36:161-174.
32. Steere AC. 2001. Lyme disease. N. Engl. J. Med. 345:115-125. (Pubitemid 32640193)
33. Stone EG, Lacombe EH, Rand PW. 2005. Antibody testing and Lyme disease risk. Emerging Infect. Dis. 11:722-724. (Pubitemid 40586399)
34. Straubinger RK, Straubinger AF, Summers BA, Jacobson RH. 2000. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study. J. Infect. Dis. 181:1069-1081. (Pubitemid 30194494)
35. Summers BA, et al. 2005. Histopathological studies of experimental Lyme disease in the dog. J. Comp. Pathol. 133:1-13. (Pubitemid 40744452)
36. Templeton TJ. 2004. Borrelia outer membrane surface proteins and transmission through the tick. J. Exp. Med. 199:603-606. (Pubitemid 38316427)
37. Töpfer KH, Straubinger RK. 2007. Characterization of the humoral immune response in dogs after vaccination against Lyme borreliosis agent. A study with five commercial vaccines using two different vaccination schedules. Vaccine 25:314-326.
38. Wagner B, Freer HH. 2009. Development of a bead-based multiplex assay for simultaneous quantification of cytokines in horses. Vet. Immunol. Immunopathol. 127:242-248.
39. Wagner B, Freer H, Rollins A, Erb HN. 2011. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum. Vet. Immunol. Immunopathol. 140:190-198.
40. Wagner B, et al. 2011. Development of a multiplex assay for detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods. Vet. Immunol. Immunopathol. 144:374-381.
41. Wieneke CA, et al. 2000. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination. J. Clin. Microbiol. 38:313-317. (Pubitemid 30043308)
42. Wikle RE, Fretwell B, Jarecki M, Jarecki-Black JC. 2006. Canine Lyme disease: one-year duration of immunity elicited with a canine OspA monovalent Lyme vaccine. Intern. J. Appl. Res. Vet. Med. 4:23-28.
43. Wittenbrink MM, Failing K, Krauss H. 1996. Enzyme-linked immunosorbent assay and immunoblot analysis for detection of antibodies to Borrelia burgdorferi in dogs. The impact of serum absorption with homologous and heterologous bacteria. Vet. Microbiol. 48:257-268.
44. Yang XF, Pal U, Alani SM, Fikrig E, Norgard MV. 2004. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 199:641-648. (Pubitemid 38316431)